The FDA has approved Novo Nordisk’s Xultophy and Sanofi’s Soliqua on the same day, pitching the rival diabetes combination into head-to-head competition. Both products combine a long acting insulin ...
N4 Pharma announced the appointment of Dr David H Solomon as its chief executive on Tuesday, and unveiled plans to rebrand as ...
N4 Pharma Plc a nommé David H Solomon au poste de directeur général . En identifiant David comme son successeur, Nigel Theobald, fondateur de la société, a quitté ses fonctions de ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Le registre des drogues innovantes est tenu en vertu de l'article C.08.004.1(9) du Règlement sur les aliments et drogues. Le registre mentionne les drogues qui sont admissibles à la protection des ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results